Werewolf Therapeutics (HOWL) Institutional Ownership → Forget the “Magnificent 7” Tech Companies, Buy This AI Stock Instead (From Banyan Hill Publishing) (Ad) Free HOWL Stock Alerts $4.87 +0.02 (+0.41%) (As of 11:00 AM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Werewolf Therapeutics (NASDAQ:HOWL)CurrentInstitutional OwnershipPercentage64.84%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$5.95MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$166.40K Get HOWL Insider Trade Alerts Want to know when executives and insiders are buying or selling Werewolf Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data HOWL Institutional Buying and Selling by Quarter Ad Smallcaps DailyThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WayNanoviricides Technology Will Transform The Way Viruses & Their Variants Are Treated Worldwide And This Company Is At The Forefront!See how with its ongoing expansion and development Werewolf Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/10/2024 Acadian Asset Management LLC172,883$1.12M0.0%+119.8%0.399% 5/10/2024 Vanguard Group Inc.1,107,347$7.18M0.0%+26.8%2.554% 5/9/2024 HBK Sorce Advisory LLC13,227$86K0.0%-50.0%0.031% 4/19/2024 Denali Advisors LLC26,600$172K0.1%N/A0.061% 2/15/2024 PFM Health Sciences LP3,468,177$13.39M0.8%+35.6%8.529% 2/14/2024 Lighthouse Investment Partners LLC22,472$87K0.0%N/A0.055% Get the Latest News and Ratings for HOWL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Werewolf Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/5/2024Certuity LLC10,000$39K0.0%N/A0.028% 2/1/2024 Financial Perspectives Inc6,750$26K0.0%+80.0%0.019% 8/4/2023 HBK Sorce Advisory LLC26,454$81K0.0%-50.0%0.074% 5/15/2023 Rubric Capital Management LP1,935,357$5.03M0.1%+5.4%5.449% 5/8/2023 Bailard Inc.18,127$47K0.0%N/A0.051% 2/9/2023 Chicago Partners Investment Group LLC10,729$41K0.0%N/A0.035% 11/15/2022 PFM Health Sciences LP2,815,654$12.70M0.5%+62.7%9.158% 11/15/2022 Platinum Investment Management Ltd.109,530$494K0.0%-48.7%0.356% 11/15/2022Laurion Capital Management LP522,900$2.36M0.0%-2.3%1.700% 11/14/2022Ergoteles LLC114,595$517K0.0%-11.2%0.388% 11/14/2022 Rubric Capital Management LP966,879$4.36M0.2%+371.7%3.274% 10/25/2022 Denali Advisors LLC5,900$27K0.0%N/A0.020% 8/15/2022Laurion Capital Management LP535,160$2.19M0.0%N/A1.935% 8/8/2022 Y Intercept Hong Kong Ltd11,124$45K0.0%N/A0.040% 7/27/2022 Bailard Inc.21,200$87K0.0%N/A0.077% 5/11/2022Granite Point Capital Management L.P.55,000$242K0.1%+266.7%0.199% 2/15/2022Adage Capital Partners GP L.L.C.960,448$11.44M0.0%-2.5%3.483% 2/14/2022Deerfield Management Company L.P. Series C958,125$11.41M0.2%-45.3%3.474% 2/14/2022Soleus Capital Management L.P.64,585$769K0.1%-88.5%0.234% 2/11/2022Granite Point Capital Management L.P.15,000$179K0.0%N/A0.054% 2/8/2022 Northern Trust Corp200,065$2.38M0.0%+184.2%0.725% 11/15/2021Deerfield Management Company L.P. Series C1,752,787$30.08M0.6%-31.3%6.358% 11/15/2021Sphera Funds Management LTD.688,475$11.81M1.0%-2.5%2.497% 11/15/2021 Caas Capital Management LP162,599$2.79M0.1%+62.6%0.590% 11/12/2021 Geode Capital Management LLC136,472$2.34M0.0%+26.2%0.495% 11/10/2021Levin Capital Strategies L.P.15,000$257K0.0%N/A0.054% 11/9/2021 BlackRock Inc.369,961$6.35M0.0%+1.1%1.342% 11/9/2021 Platinum Investment Management Ltd.213,381$3.66M0.1%+3.1%0.774% 11/8/2021 Russell Investments Group Ltd.125,873$2.16M0.0%N/A0.457% 11/2/2021 New York State Common Retirement Fund14,765$253K0.0%+13.3%0.054% 8/23/2021DC Funds LP589,102$10.27M48.8%N/A2.137% 8/17/2021Sphera Funds Management LTD.706,294$12.05M0.8%N/A2.562% 8/17/2021 PFM Health Sciences LP400,000$6.98M0.2%N/A1.451% 8/17/2021Aristides Capital LLC25,585$446K0.1%N/A0.093% The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (Ad)Nanoviricides Technology Will Transform The Way Viruses & Their Variants Are Treated Worldwide And This Company Is At The Forefront!See how with its ongoing expansion and development8/17/2021 Caas Capital Management LP100,000$1.74M0.0%N/A0.363% 8/16/2021California State Teachers Retirement System10,465$183K0.0%N/A0.038% 8/16/2021RA Capital Management L.P.4,291,881$74.85M1.2%N/A15.568% 8/16/2021Alyeska Investment Group L.P.206,201$3.60M0.0%N/A0.748% 8/16/2021Schonfeld Strategic Advisors LLC11,300$197K0.0%N/A0.041% 8/16/2021 Charles Schwab Investment Management Inc.16,038$280K0.0%N/A0.058% 8/16/2021State Street Corp78,237$1.36M0.0%N/A0.284% 8/16/2021 Nuveen Asset Management LLC12,001$209K0.0%N/A0.044% 8/16/2021Goldman Sachs Group Inc.37,435$653K0.0%N/A0.136% 8/13/2021 Northern Trust Corp75,774$1.32M0.0%N/A0.275% 8/13/2021 Geode Capital Management LLC108,178$1.89M0.0%N/A0.392% 8/13/2021MPM Asset Management LLC4,284,172$74.72M13.9%N/A15.540% 8/13/2021 Vanguard Group Inc.173,127$3.02M0.0%N/A0.628% 8/13/2021MPM Oncology Impact Management LP2,388,011$41.65M6.8%N/A8.662% 8/13/2021 FMR LLC315,000$5.49M0.0%N/A1.143% 8/12/2021 JPMorgan Chase & Co.9,352$163K0.0%N/A0.034% 8/11/2021 Arena Capital Advisors LLC CA14,958$261K0.0%N/A0.054% 8/11/2021 Bank of New York Mellon Corp22,213$387K0.0%N/A0.081% 8/11/2021 BlackRock Inc.365,863$6.38M0.0%N/A1.327% 8/11/2021Deutsche Bank AG4,492$78K0.0%N/A0.016% 8/10/2021 Nicholas Investment Partners LP294,654$5.14M0.3%N/A1.069% 8/10/2021 Citigroup Inc.2,016$35K0.0%N/A0.007% 8/4/2021 Migdal Insurance & Financial Holdings Ltd.187,500$3.27M0.0%N/A0.680% (Data available from 1/1/2016 forward) HOWL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of HOWL shares? During the previous two years, 16 institutional investors and hedge funds held shares of Werewolf Therapeutics. The most heavily invested institutionals were PFM Health Sciences LP ($13.39M), Janus Henderson Group PLC ($10.92M), Vanguard Group Inc. ($7.18M), Rubric Capital Management LP ($5.03M), Laurion Capital Management LP ($2.36M), Acadian Asset Management LLC ($1.12M), and Ergoteles LLC ($517K).Learn more on HOWL's institutional investors. What percentage of Werewolf Therapeutics stock is owned by institutional investors? 64.84% of Werewolf Therapeutics stock is owned by institutional investors. Learn more on HOWL's institutional investor holdings. Which institutional investors have been buying Werewolf Therapeutics stock? Of the 13 institutional investors that purchased Werewolf Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: PFM Health Sciences LP ($1.99M), Janus Henderson Group PLC ($1.69M), Rubric Capital Management LP ($861.85K), Laurion Capital Management LP ($535.16K), Vanguard Group Inc. ($233.91K), Acadian Asset Management LLC ($94.21K), and Bailard Inc. ($39.33K). How much institutional buying is happening at Werewolf Therapeutics? Institutional investors have bought a total of 5,537,166 shares in the last 24 months. This purchase volume represents approximately $27.89M in transactions. Which Werewolf Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Werewolf Therapeutics stock in the last 24 months: Platinum Investment Management Ltd. ($103.85K), HBK Sorce Advisory LLC ($39.68K), Ergoteles LLC ($14.41K), and Laurion Capital Management LP ($12.26K). How much institutional selling is happening at Werewolf Therapeutics? Institutional investors have sold a total of 170,197 shares in the last 24 months. This volume of shares sold represents approximately $755.02K in transactions. Related Companies: Veru Major Shareholders Merrimack Pharmaceuticals Major Shareholders Trevi Therapeutics Major Shareholders Eliem Therapeutics Major Shareholders Zevra Therapeutics Major Shareholders Ovid Therapeutics Major Shareholders Incannex Healthcare Major Shareholders Generation Bio Major Shareholders Atossa Therapeutics Major Shareholders Inventiva Major Shareholders This page (NASDAQ:HOWL) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTop 5 AI Stocks to Buy for 2024Market Moving TrendsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCharles Payne Demystifies OptionsUnstoppable ProsperityTop 5 Tech Stocks to Buy for 2024Daily Market Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Werewolf Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.